Vulnerability Details CVE-2022-45611
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Exploit prediction scoring system (EPSS) score
EPSS Score 0.002
EPSS Ranking 37.7%
CVSS Severity
CVSS v3 Score 9.8
References
- https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
- https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
- https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf
Products affected by CVE-2022-45611
-
cpe:2.3:h:fresenius-kabi:pharmahelp:-
-
cpe:2.3:o:fresenius-kabi:pharmahelp_firmware:5.1.759.0